INMB Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - INmune Bio Inc

Watchlist Manager

Watchlist

Price: 1.24 USD -2.36% Market Closed

Market Cap: $33m

	INmune Bio Inc NASDAQ:INMB	US
	Aisan Industry Co Ltd TSE:7283	JP
M	Meridian Energy Ltd ASX:MEZ	NZ
G	General Electric Co SIX:GE	US
	Kardemir Karabuk Demir Celik Sanayi ve Ticaret AS IST:KRDMD.E	TR
S	Safran SA DUS:SEJ1	FR
	Equinor ASA OSE:EQNR	NO
	Priority Technology Holdings Inc NASDAQ:PRTH	US

Profitability Summary

INmune Bio Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-61.738%

Negative 3Y Average Operating Margin

-76.417%

Declining Operating Margin

-9.958% > -61.738%

Negative Net Margin

-91.866%

Negative 3Y Average Net Margin

-81.377%

Declining Net Margin

-10.362% > -91.866%

Negative Free Cash Flow Margin

-47.248%

Negative 3Y Average Free Cash Flow Margin

-54.712%

Declining Free Cash Flow Margin

-5.754% > -47.248%

Negative ROE

-165%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-360%

Declining ROIC

-113% > -520%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.